A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects

NCT01037582 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2
Healthy

Interventions

DRUG: NN9924 (oral)
DRUG: placebo
DRUG: NN9924 (oral)
DRUG: placebo
DRUG: NN9924 (s.c.)
DRUG: NN9924 (i.v.)

Sponsor

Novo Nordisk A/S